Related references
Note: Only part of the references are listed.Secondary loss of response to mepolizumab in severe eosinophilic asthma
Maxime Cormier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma
Parameswaran Nair et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma
Grainne d'Ancona et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S. Harvey et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Prediction of response to biological treatment with monoclonal antibodies in severe asthma
J. A. Kroes et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Real-World Effectiveness and the Characteristics of a Super-Responder to Mepolizumab in Severe Eosinophilic Asthma
Joanne E. Kavanagh et al.
CHEST (2020)
Real-word experience with mepolizumab: Does it deliver what it has promised?
Florence Schleich et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Prevalence and Recovery of Adrenal Insufficiency in Steroid-Dependent Asthma Patients Receiving Biologic Therapy
Alexandra Nanzer et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
Camille Taille et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
Manali Mukherjee et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Persistence of Sinonasal Disease Despite Mepolizumab
Nicholas R. Rowan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids
Michael C. Peters et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Phenotypes and endotypes of adult asthma: Moving toward precision medicine
Ravdeep Kaur et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
Charlene M. Prazma et al.
RESPIRATORY RESEARCH (2019)
Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab
Manali Mukherjee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
J. Mark FitzGerald et al.
LANCET RESPIRATORY MEDICINE (2018)
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Timm Volmer et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Exacerbations of severe asthma in patients treated with mepolizumab
Rahul Shrimanker et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Severe and Difficult-to-Treat Asthma in Adults
Elliot Israel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Treatable traits: toward precision medicine of chronic airway diseases
Alvar Agusti et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
Hector G. Ortega et al.
LANCET RESPIRATORY MEDICINE (2016)
Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients?
Benjamin Chaigne et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma
David F. Choy et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Standardisation of spirometry
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
EF Juniper et al.
RESPIRATORY MEDICINE (2005)
Share Paper
